Markets

Insider Trading

Hedge Funds

Retirement

Opinion

These Stocks under $10 Are Poised To Explode

In this piece, we will take a look at these stocks under $10 are poised to explode. If you want to skip our introduction to these tricky stocks, jump to These 5 Stocks Under $10 Are Poised To Explode.

The US equity markets remain on track for a strong finish in 2023 as major indices hover near all-time highs. Easing inflation and a resilient economy that has avoided recession are factors that have catapulted the markets higher for the better part of the year. Will the rally continue into 2024? That’s the big question amid a wave of monetary and deteriorating macroeconomic uncertainties.

With the Federal Reserve indicating rate cuts in 2024, investors’ risk appetite is going to increase in the next year and small companies trading for low prices will come on investors’ radar. In this backdrop it would be interesting to see which under-$10 stocks have strong upside potential.

A close up shot of a stock ticker reflecting the performance of Indian equity markets.

Our Methodology

For this article we picked 10 stocks under $10 which have bullish ratings from analysts and price targets that show strong upside potential from their current levels. For each stock we have also mentioned hedge fund sentiment. Hedge funds’ top 10 consensus stock picks outperformed the S&P 500 Index by more than 140 percentage points over the last 10 years (see the details here). That’s why we pay very close attention to this often-ignored indicator.

These Stocks under $10 Are Poised To Explode

10. Annovis Bio, Inc. (NYSE:ANVS)

Share Price as of December 14: $9.70

Share Price Upside Potential: 230.39%

Number of Hedge Funds: 2

Annovis Bio, Inc. (NYSE:ANVS) is a cheap stock under $10 for anyone eyeing exposure in the healthcare sector. It operates as a clinical-stage drug platform that develops drugs for treating neurodegeneration conditions. Buntanetap, the lead product of Annovis Bio, Inc. (NYSE:ANVS), is in phase 3 trials for chronic neurodegenerative diseases like Alzheimer’s and Parkinson’s.

While Annovis Bio, Inc. (NYSE:ANVS) is down by 30% for the year, it has started showing signs of edging higher after bottoming out of all-time lows. The stock has exploded in recent weeks as its lead drug, Buntanetap, undergoes late-stage study in patients with Parkinson’s disease. Consensus estimates on Wall Street indicate Annovis Bio, Inc. (NYSE:ANVS) is a Strong Buy with a $30.33 price target, implying 230.39% upside potential.

Insider Monkey’s Q3 2023 survey of 910 hedge funds revealed that two had invested in Annovis Bio, Inc. (NYSE:ANVS).

9. ESSA Pharma Inc. (NASDAQ:EPIX)

Share Price as of December 14: $5.68

Share Price Upside Potential: 233.27%

Number of Hedge Funds: 12

ESSA Pharma Inc. (NASDAQ:EPIX) is a clinical-stage pharmaceutical company that focuses on the development of small-molecule drugs for the treatment of prostate cancer. ESSA Pharma Inc. (NASDAQ: EPIX)’s lead product is EPI-7386, an androgen receptor-based resistance mechanism that develops in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. 

After being consolidated for the better part of the year, ESSA Pharma Inc. (NASDAQ: EPIX) exploded in the second half and is up by about 114%. Analysts expect the rally to persist into 2024, going by the Buy rating and $18.33 price target, implying 233.27% upside potential.

ESSA Pharma Inc. (NASDAQ:EPIX) is getting the attention of smart money, as 12 elite hedge funds held stakes in the company in the third quarter of 2023.

8. electroCore, Inc. (NASDAQ:ECOR)

Share Price as of December 14: $5.50

Share Price Upside Potential: 236.54%

Number of Hedge Funds: 1

electroCore, Inc. (NASDAQ:ECOR) is another stock under $10 poised to explode, which is ideal for gaining exposure in the healthcare sector. electroCore, Inc. (NASDAQ:ECOR) operates as a commercial-stage bioelectronics medicine and wellness company. 

electroCore, Inc. (NASDAQ:ECOR) has gained about 35% year to date, outperforming the S&P 500, which is up by about 21%. Likewise, analysts on Wall Street are overly optimistic about electroCore, Inc. (NASDAQ:ECOR), with a Buy rating and a $17.50 price target, implying a 236.54% upside potential. One hedge fund was long electroCore, Inc. (NASDAQ:ECOR) in the third quarter of 2023.

7. Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM)

Share Price as of December 14: $1.31

Share Price Upside Potential: 237.41%

Number of Hedge Funds: 10

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) is another cheap stock under $10 poised to explode, operating as a clinical-stage pharmaceutical company that develops and commercializes therapies for people with rare genetic mitochondrial diseases. REN001, the lead product of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM), is a strong and specific drug that activates a protein involved in energy metabolism. It is being tested for inherited diseases that affect the mitochondria.

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM)’s been one of the best-performing cheap stocks in 2023, rallying by about 204%. Similarly, analysts on Wall Street expect the rally to persist into 2024, going by a $24.26 price target, implying a 237.41% upside potential.

By the end of this year’s September quarter, 10 out of the 910 hedge funds provided by Insider Monkey had acquired and held shares of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM).

6. Zepp Health Corporation (NYSE:ZEPP)  

Share Price as of December 14: $1.51

Share Price Upside Potential: 238.67%

Number of Hedge Funds: 3

Zepp Health Corporation (NYSE:ZEPP) is an innovative wearable and health technology company. The company empowers people to live lives by optimizing health, fitness, and wellness journeys through its consumer brands Amazfit, Zepp Clarity, and Zepp Aura. Zepp Health Corporation (NYSE:ZEPP) offers AI chips, biometric sensors, and data algorithms for its cloud-based actionable insights.

Zepp Health Corporation (NYSE:ZEPP) is up by about 3.4% for the year as analysts on Wall Street rate it as a buy with a $5.08 price target, implying a 238.67% upside potential. Zepp Health Corporation (NYSE:ZEPP) trades at highly discounted levels, going by the 5.13 price-to-earnings ratio.

According to Insider Monkey’s third-quarter database, three hedge funds were bullish on Zepp Health Corporation (NYSE:ZEPP), the same as the previous quarter.

Click to continue reading and see The 5 Stocks Under $10 That Are Poised To Explode.

Suggested articles:

Disclosure: None. These Stocks under $10 Are Poised To Explode is originally published on Insider Monkey.

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

AI is eating the world—and the machines behind it are ravenous.

Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink.

Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and building the digital future. But there’s one urgent question few are asking:

Where will all of that energy come from?

AI is the most electricity-hungry technology ever invented. Each data center powering large language models like ChatGPT consumes as much energy as a small city. And it’s about to get worse.

Even Sam Altman, the founder of OpenAI, issued a stark warning:

“The future of AI depends on an energy breakthrough.”

Elon Musk was even more blunt:

“AI will run out of electricity by next year.”

As the world chases faster, smarter machines, a hidden crisis is emerging behind the scenes. Power grids are strained. Electricity prices are rising. Utilities are scrambling to expand capacity.

And that’s where the real opportunity lies…

One little-known company—almost entirely overlooked by most AI investors—could be the ultimate backdoor play. It’s not a chipmaker. It’s not a cloud platform. But it might be the most important AI stock in the US owns critical energy infrastructure assets positioned to feed the coming AI energy spike.

As demand from AI data centers explodes, this company is gearing up to profit from the most valuable commodity in the digital age: electricity.

The “Toll Booth” Operator of the AI Energy Boom

  • It owns critical nuclear energy infrastructure assets, positioning it at the heart of America’s next-generation power strategy.
  • It’s one of the only global companies capable of executing large-scale, complex EPC (engineering, procurement, and construction) projects across oil, gas, renewable fuels, and industrial infrastructure.
  • It plays a pivotal role in U.S. LNG exportation—a sector about to explode under President Trump’s renewed “America First” energy doctrine.

Trump has made it clear: Europe and U.S. allies must buy American LNG.

And our company sits in the toll booth—collecting fees on every drop exported.

But that’s not all…

As Trump’s proposed tariffs push American manufacturers to bring their operations back home, this company will be first in line to rebuild, retrofit, and reengineer those facilities.

AI. Energy. Tariffs. Onshoring. This One Company Ties It All Together.

While the world is distracted by flashy AI tickers, a few smart investors are quietly scooping up shares of the one company powering it all from behind the scenes.

AI needs energy. Energy needs infrastructure.

And infrastructure needs a builder with experience, scale, and execution.

This company has its finger in every pie—and Wall Street is just starting to notice.

Wall Street is noticing this company also because it is quietly riding all of these tailwinds—without the sky-high valuation.

While most energy and utility firms are buried under mountains of debt and coughing up hefty interest payments just to appease bondholders…

This company is completely debt-free.

In fact, it’s sitting on a war chest of cash—equal to nearly one-third of its entire market cap.

It also owns a huge equity stake in another red-hot AI play, giving investors indirect exposure to multiple AI growth engines without paying a premium.

And here’s what the smart money has started whispering…

The Hedge Fund Secret That’s Starting to Leak Out

This stock is so off-the-radar, so absurdly undervalued, that some of the most secretive hedge fund managers in the world have begun pitching it at closed-door investment summits.

They’re sharing it quietly, away from the cameras, to rooms full of ultra-wealthy clients.

Why? Because excluding cash and investments, this company is trading at less than 7 times earnings.

And that’s for a business tied to:

  • The AI infrastructure supercycle
  • The onshoring boom driven by Trump-era tariffs
  • A surge in U.S. LNG exports
  • And a unique footprint in nuclear energy—the future of clean, reliable power

You simply won’t find another AI and energy stock this cheap… with this much upside.

This isn’t a hype stock. It’s not riding on hope.

It’s delivering real cash flows, owns critical infrastructure, and holds stakes in other major growth stories.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 100+% Return within 12 to 24 months.

We’re now offering month-to-month subscriptions with no commitments.

For a ridiculously low price of just $9.99 per month, you can unlock our in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…